Introduction
Posttranslational modification, including phosphorylation, ubiquitination, and lipid modification, adds functional regulation to proteins beyond genomic information. Lipid modification increases protein hydrophobicity and plays a critical role in protein trafficking, targeting, and function. Thioester-linked palmitate modifies signaling proteins, enzymes, cytoskeletal proteins, ion channels, and scaffolding proteins and is involved in diverse aspects of cellular signaling Resh, 2006; Linder and Deschenes, 2007) . Recent global proteomic analyses have further expanded the known complement of palmitoylated proteins (Roth et al., 2006; Kang et al., 2008) . Palmitoylation is unique in that it is a reversible modification and is proposed to be regulated by specific extracellular signals. Recent cell biological analyses revealed that some palmitoyl substrates such as small GTPases, Harvey Ras/neuroblastoma Ras (Rocks et al., 2005) , and trimeric G proteins Go (Chisari et al., 2007) /Gq (Tsutsumi et al., 2009) constitutively shuttle between the plasma membrane and the Golgi membrane by a palmitoylation/depalmitoylation cycle. This palmitate cycling generates and maintains the specific intracellular compartmentalization of substrates in nonpolarized cells (Rocks et al., 2006) .
The postsynaptic scaffolding protein PSD-95 represents a major palmitoylated protein in neurons and plays critical roles in synaptogenesis and synaptic plasticity (Migaud et al., 1998; El-Husseini et al., 2000; Kennedy, 2000; Kim and Sheng, 2004; Funke et al., 2005) . PSD-95 provides a platform for the postsynaptic clustering of crucial synaptic proteins, including AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionic P rotein palmitoylation is the most common posttranslational lipid modification; its reversibility mediates protein shuttling between intracellular compartments. A large family of DHHC (Asp-His-His-Cys) proteins has emerged as protein palmitoyl acyltransferases (PATs). However, mechanisms that regulate these PATs in a physiological context remain unknown. In this study, we efficiently monitored the dynamic palmitate cycling on synaptic scaffold PSD-95. We found that blocking synaptic activity rapidly induces PSD-95 palmitoylation and mediates synaptic clustering of PSD-95 and associated AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type glutamate receptors. A dendritically localized DHHC2 but not the Golgi-resident DHHC3 mediates this activity-sensitive palmitoylation. Upon activity blockade, DHHC2 translocates to the postsynaptic density to transduce this effect. These data demonstrate that individual DHHC members are differentially regulated and that dynamic recruitment of protein palmitoylation machinery enables compartmentalized regulation of protein trafficking in response to extracellular signals.
Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95 palmitoylation-deficient (CS) mutant PSD-95 or GFP (Fig. 1, A and B). We confirmed comparable expression levels of PSD-95 (WT) and PSD-95 (CS) in transfected culture (Fig. 1 B) . These data confirm that palmitoylation mediates membrane trafficking and synaptic clustering of PSD-95 (Topinka and Bredt, 1998) . Because PSD-95 visualized by TIRFM apposes presynaptic synaptophysin and VGLUT1 and overlaps postsynaptic NR1 NMDA receptor (Fig. 1 C) , TIRFM tracks synaptic PSD-95. When ionotropic glutamate receptor activity was blocked by kynurenic acid (Kyn), the intensity of PSD-95-GFP by TIRFM steadily increased over 2 h, whereas the intensity of PSD-95 (CS) did not change (Fig. 1, D and E; and Video 1) . This Kyninduced PSD-95 increase was blocked by coapplication of 2-bromopalmitate (2-BP), which is a palmitoyl acyl transfer inhibitor. PSD-95 signals did not detectably change within 2 h of 2-BP treatment alone (Fig. 1 E) . These results indicate that newly occurring palmitoylation mediates this synaptic accumulation of PSD-95. Tetrodotoxin (TTX), a blocker of action potentials, also increased PSD-95 accumulation. The dynamic change of PSD-95 intensity was specific to palmitoylation as the localizations of GFP-Rac1-CLLL (Cys-Leu-Leu-Leu), a geranylgeranylated CaaL motif, and synaptophysin-GFP, a presynaptic protein, did not change upon Kyn treatment (Fig. 1 E) . Synaptic PSD-95 accumulation upon activity blockade was also confirmed by antibody staining of native PSD-95 (see To monitor PSD-95 palmitoylation biochemically, we used the acyl-biotin exchange (ABE) method (Roth et al., 2006; Kang et al., 2008) . We confirmed that this method specifically identified palmitoylated proteins, including PSD-95, in heterologous cells (Fig. S2 A) . As previously reported , treating neurons for 12 h with 2-BP reduced PSD-95 palmitoylation (palmitoylated PSD-95 = 13 ± 15% of control cells; P < 0.001; Fig. 2 A) . When we treated neurons for 2 h with Kyn, the amount of palmitoylated PSD-95 significantly increased (198 ± 13% of control cells; P < 0.001; Fig. 2, A and B) . Blocking glutamate receptors with a combination of APV (D-[-]-2-amino-5-phosphonopentanoic acid), which blocks NMDA receptors, and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), which blocks AMPARs, also enhanced PSD-95 palmitoylation within 2 h (palmitoylated PSD-95 = 184 ± 23% of control cells; P < 0.01). 2-BP blocked the rapid enhancement of PSD-95 palmitoylation, indicating that inhibition of depalmitoylation is not solely responsible and that newly occurring palmitoylation mediates this effect. This activity-sensitive PSD-95 palmitoylation is stoichiometric, as Kyn and APV + CNQX quantitatively acid) and N-methyl-d-aspartate (NMDA)-type glutamate receptors and cell adhesion molecules. The postsynaptic targeting of PSD-95 depends on protein palmitoylation (Topinka and Bredt, 1998) . Importantly, palmitate cycling on PSD-95 is dynamically regulated by receptor activation . Upon glutamate receptor stimulation, accelerated depalmitoylation of PSD-95 dissociates PSD-95 from postsynaptic sites and causes AMPA receptor (AMPAR) endocytosis. This receptor activation-induced depalmitoylation has also been reported in G (Wedegaertner and Bourne, 1994) . Thus, agonistdependent depalmitoylation down-regulates synaptic strength and G protein signaling. However, it is not yet clear whether addition of palmitate to proteins is accelerated in response to extracellular signals.
The dynamic regulation of palmitate cycling should be finely tuned by palmitoyl acyltransferases (PATs) and palmitoyl protein thioesterases (PPTs). Transmembrane proteins containing a DHHC (Asp-His-His-Cys) Cys-rich domain (DHHC proteins) have recently emerged as PATs in yeast (Bartels et al., 1999; Lobo et al., 2002; Roth et al., 2002; Linder and Deschenes, 2004) . At least 23 mammalian DHHC proteins exist, and a systematic screening method has identified specific enzyme-substrate pairs Fang et al., 2006; Fernandez-Hernando et al., 2006; Fukata et al., 2006; Ponimaskin et al., 2008; Tsutsumi et al., 2009) . The DHHC family is present in species ranging from yeast to human and to plants (Hemsley et al., 2005; Hemsley and Grierson, 2008) . Several DHHC genes are associated with diseases, including cancers (Oyama et al., 2000) , schizophrenia (Mukai et al., 2004 (Mukai et al., , 2008 , mental retardation (Mansouri et al., 2005; Raymond et al., 2007) , and Huntington's (Yanai et al., 2006) . Although the large DHHC family plays essential roles in a range of physiological functions, how the DHHC PAT family is regulated and thereby dynamically controls palmitate cycling remains uncertain.
In this study, we found that suppression of neuronal activity induces palmitoylation and synaptic accumulation of PSD-95. This activity-sensitive PSD-95 palmitoylation recruits synaptic AMPARs. Dendritically localized DHHC2 mediates this rapid synaptic palmitoylation of PSD-95. In contrast, Golgi-resident DHHC3 constitutively palmitoylates PSD-95. These experiments indicate that large DHHC family members are individually regulated, which enables their participation in specific physiological processes such as synaptic plasticity. To follow changes in synaptic PSD-95 accumulation over time, we first performed time-lapse imaging of cultured hippocampal neurons transfected with PSD-95-GFP by TIRFM, which excites only molecules within 100 nm of the cover glass. TIRFM preferentially visualizes wild-type (WT) PSD-95-GFP as discrete punctae on dendrites, which are not seen with cytosolic and -7 (Tsutsumi et al., 2009) , and GluR2 PAT is DHHC3 (Fig. S2 C; Hayashi et al., 2005) . These substrate selectivities allowed us to ask whether synaptic activity regulates a specific PAT subfamily (i.e., DHHC2/15). We metabolically labeled hippocampal neurons with [ 3 H]palmitic acid for 2 h in the presence or absence of Kyn. We found that Kynenhanced PSD-95 palmitoylation was partially blocked by a dominant-negative (DN) mutant, DN-DH2/15, which specifically inhibits the DHHC2/15 subfamily (palmitoylated PSD-95 = 61 ± 15% of Kyn-treated control cells; P < 0.01; Fig. S2 B) . This upward shift reflects palmitoylation, as -mercaptoethanol (ME), which hydrolyses the palmitoyl thioester, leaves only the lower band (Fig. 2, A and B, bottom) . Both the increased PSD-95 palmitoylation and synaptic accumulation were reversible upon washing out of Kyn, indicating that this process is activity sensitive (Fig. 2 , B and C).
Results

Total
This activity-sensitive palmitoylation is specific for PSD-95, as Gq, GluR2, and GRIP1 palmitoylation did not change upon activity blockade (Fig. 2, A and B) . Our previous study demonstrated that PATs are DHHC2, -3, -7, and -15, which are phylogenetically divided into two subfamilies, DHHC3/7 and DHHC2/15 . Gq PATs are . These results indicate that DHHC3 localizes to the Golgi apparatus and mediates constitutive palmitoylation of various substrates, including PSD-95, Gq, and GABA A receptor- subunit Keller et al., 2004; Tsutsumi et al., 2009 ). In contrast, dendritic DHHC2 mediates activity-sensitive PSD-95 palmitoylation.
Dendritic DHHC2 translocates near postsynaptic sites upon activity blockade
We next investigated whether DHHC2 PAT activity, monitored by autopalmitoylation , was regulated by synaptic activity. Whereas PSD-95 palmitoylation increased which correlates with the extent of inhibition (40% inhibition). Although the involvement of other PATs cannot be completely ruled out, our results strongly suggest that the DHHC2/15 subfamily plays a major role in activity-sensitive PSD-95 palmitoylation.
Differential regulation of PSD-95 palmitoylating enzymes in neurons
We next examined the cellular locus for PSD-95 palmitoylation. We focused on DHHC2 and -3, as hippocampal neurons express these PATs but much less DHHC7 and -15 (Fig. S3 A) . Immunoblotting with specific antibodies (Fig. 3 A) showed that DHHC2 occurred in the postsynaptic density fraction, whereas DHHC3 was present only in the P3 fraction, which contains Golgi proteins (Fig. 3 B) . Consistent with this finding, DHHC3 specifically localizes to the somatic Golgi apparatus (Keller et al., 2004; Tsutsumi et al., 2009) , whereas DHHC2 distributes in the dendrites and cell body as small vesicular-like structures (Fig. 3 C) . These signals are specific, as the staining completely disappeared in the validated knockdown vector-transfected neuron (Fig. 3 D) . pHluorin-tagged GluR1 (pH-GluR1) subunit (Ashby et al., 2004; Yudowski et al., 2007) and TIRFM imaging to monitor specifically surface-expressed GluR1 (Video 5). pH-GluR1 punctate intensity was invariant over 12 h (Fig. 7, A and D; and Video 6) . In contrast, TTX treatment gradually and continually increased pH-GluR1 intensity (Fig. 7 , B and D; and Video 7). By post hoc immunostaining with PSD-95, we found that pH-GluR1 punctae by TIRFM completely overlapped PSD-95 clusters (Fig. 7 C) . Furthermore, knockdown of DHHC2 or PSD-95 completely blocked this increase of pH-GluR1 intensity (Fig. 7, D and E) . The effect of DHHC2 knockdown was rescued by miDHHC2-resistant WT DHHC2 (WT) but not by PAT-inactive DHHC2 (CS) (Fig. 7 E and Video 8) . The effect of PSD-95 knockdown was rescued by short hairpin RNA-resistant WT PSD-95 (WT) but not by palmitoylation-deficient PSD-95 (CS) (Fig. 7 E, Fig. S4 D, and Video 9). We also found that knockdown of DHHC2 or PSD-95 similarly inhibited Kyn-induced increase of pH-GluR1 (Fig. 7 D) . pH-GluR2, endogenous GluR1, GluR2, and stargazinlike TARPs but neither NR2A NMDA receptor nor VGLUT1 showed an increase similar to that of pH-GluR1 (Fig. S5) .
upon TTX or Kyn treatment, autopalmitoylation of DHHC2 and -3 did not change (Fig. 6 A) , suggesting that DHHC2 activity may remain constant. We then investigated whether DHHC2 localization is regulated by synaptic activity. TIRFM imaging revealed that more DHHC2 was recruited near the membrane upon Kyn or TTX treatment (Fig. 6 , B and C; and Video 4), where PSD-95 localized (Fig. S4 A) . This translocation was activity sensitive as it was reversible upon washing out of Kyn (Fig. 6 D) . Furthermore, we found that Kyn or TTX steadily induced colocalization of endogenous DHHC2 with PSD-95 over 48 h (Fig. 6 , E and F), whereas DHHC3 remained at the Golgi apparatus (Fig. S4 B) .
Activity-sensitive PSD-95 palmitoylation by DHHC2 is necessary for homeostatic increase of AMPARs
Because PSD-95 anchors AMPARs at the postsynaptic sites through interaction with stargazin and related transmembrane AMPAR regulatory proteins (TARPs; Chen et al., 2000; Nicoll et al., 2006) , we investigated changes in synaptic AMPARs upon activity blockade. We took advantage of the Similar inhibitory effects of DHHC2 or PSD-95 knockdown were observed for endogenous GluR1, GluR2, and TARPs (Fig. S5 G) . These results indicate that activity-sensitive PSD-95 palmitoylation by DHHC2 mediates the homeostatic increase of AMPARs.
Discussion
By contrasting two representative PSD-95 palmitoylating enzymes, this study is the first to define differential regulation of DHHC-type palmitoylating enzymes. DHHC3 stably localizes at the Golgi apparatus and constitutively palmitoylates numerous substrates, including G, GluR2, and PSD-95. In contrast, dendritically localized DHHC2 senses changes in synaptic activity and rapidly translocates near postsynaptic membranes. Synaptically translocated DHHC2 induces rapid, specific, and stoichiometric palmitoylation and synaptic accumulation of PSD-95 and thereby AMPAR recruitment at postsynaptic sites. Thus, activity-sensitive DHHC2 translocation marks sites for AMPAR accumulation through compartmentalized PSD-95 palmitoylation. Complementing these findings, previous works showed that the Drosophila melanogaster DHHC17/HIP14 homologue localizes primarily to presynaptic terminals and acts on presynaptic Cys string protein and SNAP-25 (Ohyama et al., 2007; Stowers and Isacoff, 2007) . The DHHC family members show distinctive subcellular distributions and different intracellular dynamics upon physiological stimuli. These distinctive properties provide mechanisms for specific control of protein palmitoylation by the large family of DHHC proteins.
Recent fluorescence recovery after photobleaching and photoconversion analyses revealed that several palmitoylated proteins such as Harvey Ras/neuroblastoma Ras (Rocks et al., 2005) , Go (Chisari et al., 2007) , and Gq (Tsutsumi et al., 2009) rapidly shuttle between the plasma membrane and the Golgi apparatus. This constitutive shuttling comprises four steps: (1) palmitoylation by the Golgi-resident DHHC proteins, (2) trafficking to the plasma membrane, (3) depalmitoylation by a putative PPT and rapid cytosolic diffusion, and (4) transient trapping at the Golgi for repalmitoylation (Fig. 8 A; Rocks et al., 2006; Tsutsumi et al., 2009 ). In neurons, where the Golgi apparatus is segregated from the axon and dendrites, we suggest that Golgi-localized DHHC3 mediates the constitutive palmitoylation of PSD-95 at the cell body. In dendrites, PSD-95 depalmitoylated at the postsynaptic membrane diffuses from dendritic spine to shaft, is repalmitoylated on DHHC2-positive vesicles, and is redirected to postsynaptic membranes (Fig. 8 B) . When synaptic activity is blocked, DHHC2 vesicles translocate from dendritic shafts to sites near the postsynaptic membrane. This allows DHHC2 to repalmitoylate PSD-95 in the spine (Fig. 8 C) . Thus, mobile DHHC2 induces a local increase of PSD-95 palmitoylation, which leads to AMPAR recruitment. We propose that extracellular signals translocate specific DHHC PATs and create a new route for substrate shuttling between loci of palmitoylation and depalmitoylation, leading to efficient and precise substrate targeting. Such a compartmentalized regulatory mechanism of DHHC PATs may contribute to spatiotemporal supplemented with epifluorescent and confocal microscopic analyses on endogenous PSD-95. Also, our biohemical approaches, including metabolic labeling and the ABE method, showed that blocking synaptic activity quantitatively increases endogenously palmitoylated PSD-95, supporting the specificity of TIRFM imaging as a method for monitoring palmitoylated proteins in living cells.
A previous study reported that glutamate receptor activation accelerates depalmitoylation of PSD-95, dissociates PSD-95 from postsynaptic sites, and causes AMPAR endocytosis regulation of signaling molecules in polarized neurons, epithelial cells, and migrating cells.
This study monitors intracellular dynamics of palmitoylated proteins by taking advantage of time-lapse TIRFM, which visualizes membrane-associated proteins with exquisite sensitivity. This approach allowed us to follow dynamic changes in membrane-associated PSD-95-GFP over time in individual neurons. However, one may ask whether endogenous PSD-95 shows similar dynamics and whether TIRFM visualizes a limited set of synaptic contacts. The TIRFM limitation was Recently, it was shown that both PSD-95 and PSD-93 play important roles in AMPAR trafficking (Elias et al., 2006) . In this study, we found that knockdown of PSD-95 alone completely blocks the TTX-or Kyn-induced recruitment of AMPARs to the synapse. One may wonder why knockdown of PSD-95 alone completely blocks the TTX-or Kyn-induced AMPAR recruitment. We quantified expression levels of PSD-95 and PSD-93 in our cultured 18-d in vitro (DIV) hippocampal neurons by quantitative Western blotting. We found that PSD-95 expresses about eight times as much as PSD-93 (Fig. S3 B) . Furthermore, we found that PSD-93-, one of the major PSD-93 isoforms (Firestein et al., 2000; Parker et al., 2004) , is specifically palmitoylated by the DHHC3 and -7 subfamily but not . This sequence suggested that a PPT serves as the regulatory trigger. In contrast, our work demonstrates that activity blockade-induced PSD-95 palmitoylation up-regulates synaptic AMPARs. Thus, the palmitoylation/ depalmitoylation cycle of PSD-95 bidirectionally contributes to AMPAR homeostasis (O'Brien et al., 1998; Turrigiano et al., 1998; Stellwagen and Malenka, 2006) . By analogy, -adrenergic receptor activation markedly accelerates depalmitoylation of Gs, shifts Gs to the cytoplasm, and down-regulates -adrenergic receptor-mediated signaling (Wedegaertner and Bourne, 1994) . Collectively, these studies suggest that palmitate cycling may generally mediate homeostasis of receptormediated signaling. DHHC2 was also subcloned into pGW1-GFP. To obtain Thy1/pH-GluR1, we first inserted pHluorin between residues 21 and 22 of rat GluR1 (Tomita et al., 2004) and subcloned pH-GluR1 into a Thy1 expression cassette. pCAGGS-pH-GluR2 was made by inserting pHluorin between residues 23 and 24 of mouse GluR2 (Fukata et al., 2005) . cDNA of NR2A-GFP (Luo et al., 2002) was subcloned into the pCAGGS vector.
In cultured hippocampal neurons, DHHC2 and -3 were knocked down by the miR-RNAi system (Invitrogen). We used BLOCK-iT RNAi Designer (Invitrogen) to select the targeting sequences, and the following targeting sequences were used (targeting both rat and human sequences): miDHHC2, 5-GGTGAACAATTGTGTTGGATT-3 (alternative sequence, 5-TGTGCATAGTGTCCATGGAAA-3; both sequences yielded similar results); miDHHC3, 5-TGAGACGGGAATAGAACAATT-3; and miLacZ, 5-GACTA-CACAAATCAGCGATTT-3 (as a negative control). After subcloning these oligonucleotides into pcDNA6.2-EmGFP-miR (Invitrogen), EmGFP was replaced with mCherry, and the pre-miRNA expression cassette of pcDNA6.2-mCherry-miR (or pcDNA6.2-EmGFP-miR) was transferred to the pCAGGS vector with a -actin promoter. PSD-95 was knocked down as described previously (Elias et al., 2006) , replacing GFP of pLLox3.7 (American Type Culture Collection) with mCherry. DHHC2 (on pEF-Bos-HA-rat DHHC2) and PSD-95 (on pGW1-rat PSD-95-HA) rescue constructs that have two and four different nucleotides in the target sequences were generated by using site-directed mutagenesis (DHHC2, 5-GGTGAACAACTGCGTTGGATT-3; PSD-95, 5-TCACAATAATAGCCCAGTATA-3; changed nucleotides are underlined). All PCR products were analyzed by DNA sequencing.
pcDNAI-Gq-GFP was provided by C.A. Berlot (Weis Center for Research, Danville, PA; Hughes et al., 2001) . The cDNAs of pHluorin and mCherry were provided by J.E. Rothman (Columbia University, New York, NY; Miesenbock et al., 1998) and R.Y. Tsien (University of California, San Diego, La Jolla, CA; Shaner et al., 2005) , respectively. cDNAs of rat GluR1, NR2A-GFP, and pEGFP-C1-Rac1-CLLL were gifts from R. Huganir (Johns Hopkins University, Baltimore, MD), S. Vicini (Georgetown University School of Medicine, Washington, DC), and K. Kaibuchi (Nagoya University, Showa-Ku, Nagoya, Japan), respectively. Thy1 expression cassette was provided by D. Monard (Friedrich Miescher Institute, Basel, Switzerland; Luthi et al., 1997) .
Time-lapse imaging with TIRFM Hippocampal neuron cultures were prepared from rat embryonic day 18-19 embryos. All animal experiments described herein were reviewed and approved by the ethical committee in our institutes and were performed according to the institutional guidelines concerning the care and handling of experimental animals. Neurons were seeded at a density of 2.5 × 10 5 cells per 3.5-cm glass-based dish (Iwaki) in neurobasal medium (Invitrogen) supplemented with B-27 supplement (Invitrogen) and 2 mM Glutamax (Invitrogen). 8-10-DIV neurons were transfected by Lipofectamine 2000 (Invitrogen) and observed (18-21 DIV) at 37°C in a microincubator (MI-IBC-IF; Olympus) with an inverted microscope (IX81; Olympus) equipped with a Plan-Apochromat 100× NA 1.45 oil TIRFM objective lens, an ImageEM charge-coupled device (CCD) camera (C9100-13; Hamamatsu Photonics) and Meta Imaging software version 7.1 (MDS Analytical Technologies). A 488-nm laser was used as a light source. Timelapse images were taken every 10 min with a laser-based zero drift autofocusing system (IX81-ZDC; Olympus), which adjusts the focal plane to the initial focal plane just before each imaging frame. The video files (QuickTime Movie) were produced with ImageReady 2.0 (Adobe Systems, Inc.). To quantitate changes in PSD-95-GFP, DHHC2-GFP, or pH-GluR1 intensity by TIRFM, we randomly chose fields, and the punctae (>1.25 µm in diameter) were quantitated in every frame. Fluorescent intensities from TIRF images were analyzed using MetaMorph software version 7.1 (MDS Analytical Technologies). The ratios of intensities at 0-120 min (for PSD-95 and DHHC2) or 0-12 h (for GluR1) in 50-100 randomly selected punctae (three to eight independent experiments) are shown. Kymographs were produced using Meta Imaging software version 7.1.
Immunofluorescence analysis of hippocampal neuron culture Cultured hippocampal neurons (5 × 10 4 cells) were seeded onto 12-mm coverslips in 24-well dishes. 18-28-DIV neurons were fixed with 4% paraformaldehyde/120 mM sucrose/100 mM Hepes, pH 7.4, at room temperature for 10 min, permeabilized with 0.1% Triton X-100 for 10 min, and blocked with PBS containing 10 mg/ml BSA for 10 min on ice. For staining of DHHC2 and VGLUT1, neurons were fixed with methanol for 10 min at 30°C. For mouse anti-DHHC2 antibody, Alexa Fluor 488-conjugated anti-mouse IgG 1 subtype specific (Invitrogen) was used as a secondary antibody. For surface GluR1 and GluR2 staining, GluR1 and GluR2 receptors were "live" labeled with an antibody to an extracellular by the DHHC2 and -15 subfamily (Fig. S3 C) , indicating that PSD-93- palmitoylation is differently regulated from PSD-95 palmitoylation. Furthermore, it was reported that palmitoylation of PSD-93- and PSD-93- is not necessary for their postsynaptic targeting (Firestein et al., 2000) . Collectively, we conclude that PSD-95 plays a major role in DHHC2-mediated AMPAR recruitment upon activity blockade.
Global proteomic studies indicate that palmitoylation represents a common posttranslational modification (Roth et al., 2006; Kang et al., 2008) . Importantly, many palmitoylated proteins are key signaling molecules that subserve physiological processes. Furthermore, mutations of DHHC family members have been detected in cancers (Oyama et al., 2000; Mansilla et al., 2007; Yamamoto et al., 2007) and neurological disorders (Mukai et al., 2004 (Mukai et al., , 2008 Mansouri et al., 2005; Yanai et al., 2006; Raymond et al., 2007) . Elucidation of molecular mechanisms for palmitoylation lays a foundation to understand its role in physiological and pathological conditions. Because DHHC enzymes show substrate specificity, DHHC PATs represent exciting therapeutic targets. Our experiments of differential partitioning and regulation on DHHC PATs should serve as a prototype for understanding how dynamic protein palmitoylation is regulated in divergent signaling environments.
Materials and methods
Materials
The following antibodies were used: rabbit polyclonal antibodies to DHHC3/GODZ (Abcam), Gq (Santa Cruz Biotechnology, Inc.), GluR1 (EMD; Millipore), GRIP1 (Millipore), , and stargazin/ TARP (Millipore); a guinea pig polyclonal antibody to VGLUT1 (Millipore); and mouse monoclonal antibodies to -catenin (BD), GluR2 (Millipore), HA (Covance), NMDAR1 (Millipore), PSD-95 (Thermo Fisher Scientific), and synaptophysin (Sigma-Aldrich). Anti-PSD-93 antibody was raised against (aa 336-379) and detected all isoforms of PSD-93. Rabbit polyclonal antibodies to GFP, PSD-95, and moesin were raised against GFP (aa 1-239), GST-PSD-95 (aa 1-434), and GST-moesin (aa 307-577), respectively, and affinity purified. A mouse monoclonal antibody to DHHC2 was raised by a baculovirus display method, which is useful for the production of antibodies against membrane proteins (Masuda et al., 2003; Saitoh et al., 2007) . The following reagents were used: Kyn and APV (Tocris); TTX (Nacalai Tesque, Inc.); CNQX and CHX (Sigma-Aldrich); and 2-bromohexadecanoic acid (2-BP; Fluka).
For knockdown experiments in HEK293 cells, siRNAs from QIAGEN were used: scramble (Allstars negative control), siDHHC2, and siDHHC3. siRNA and plasmid-based miRNA for DHHCs were validated by two methods: (1) reduced expression of exogenously expressed DHHC proteins in HEK293 cells (Western blotting) and (2) down-regulation of endogenous mRNAs in HEK293 cells (quantitative real-time PCR).
Cloning and plasmid constructions
The rat cDNAs of synaptophysin (GenBank/EMBL/DDBJ accession no. NM_012664), DHHC2 (GenBank/EMBL/DDBJ accession no. AF228917), DHHC3 (GenBank/EMBL/DDBJ accession no. NM_001039014), DHHC7 (GenBank/EMBL/DDBJ accession no. NM_133394), and DHHC15 (GenBank/EMBL/DDBJ accession no. AY886531) were cloned from rat brain total RNA by RT-PCR. Synaptophysin was subcloned into pCAGGS-GFP, and DHHC2, -3, -7, and -15 were subcloned into pEF-Bos-HA and pcDNA3.1. The mutant rat DHHC2(C156S) was generated by using sitedirected mutagenesis. pGW1-rat PSD-95-GFP, pGW1-rat PSD-93--GFP and pEF-Bos-HA-mouse DHHC constructs were described previously (ElHusseini et al., 2002; Fukata et al., 2004; Parker et al., 2004) . pGW1-PSD-95-HA was constructed by replacing a GFP fragment with a synthetic DNA fragment encoding HA. pEGFP-C1-Rac1-CLLL was described previously (Nakagawa et al., 2001) . To obtain the antigen for antibody production, DHHC2 was subcloned into the pcDNA-His-Flag vector. His-Flag-tagged DHHC2 was then subcloned into pAcYM1 for baculovirus production. treated with Amplify (GE Healthcare) for 30 min, dried under vacuum, and exposed to Biomax MS (Kodak) at 80°C for 2 wk. After autoradiography, the bands were scanned and analyzed with National Institutes of Health software.
Transfected HEK293 cells were preincubated for 30 min in serumfree DME with 5 mg/ml fatty acid-free BSA (Sigma-Aldrich). Cells were then labeled with 0.25 mCi/ml [ 3 H]palmitic acid for 4 h in the preincubation medium. Cells were washed with PBS and scraped with SDS-PAGE sample buffer with 10 mM DTT. The cell lysate was resolved by SDS-PAGE, followed by fluorography (36-h exposure) and Western blotting.
In situ hybridization
In situ hybridization on 7-µm paraffin-embedded 3-wk-old rat brain sections (Genostaff) was performed by using digoxigenin-labeled RNA probes. cDNAs of mouse DHHC2 (nt 1-1,098 from initiating ATG), rat DHHC3 (nt 1-900), rat DHHC7 (nt 1-927), rat DHHC15 (nt 1-1,014), and rat PSD-95 (nt 1,212-1,444) were used for probe templates. An antidigoxigenin antibody linked to alkaline phosphatase (Dako) and NBT/BCIP (nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate; Dako) substrate was used to detect hybridization signals. All sections were developed for 1 h. Images were taken with a dissection microscope (SZ61; Olympus) equipped with a digital camera (DP20; Olympus) and with an upright microscope (BX51; Olympus) equipped with a UPlan SApo 20× NA 0.75 objective lens and a CCD camera (DP72; Olympus).
Quantitative Western blotting
Bands on blotted membranes were visualized with a cooled CCD camera (Light-Capture II; ATTO), and the optimal specific bands were analyzed with the CS Analyzer 3.0 software (ATTO). For calibration, immunopurified PSD-95-GFP and PSD-93--GFP from transfected HEK293 cells were quantitated by Coomassie brilliant staining using BSA.
Subcellular fractionation
The method was basically followed as described previously (Carlin et al., 1980) . In brief, five rat adult brains were homogenized in buffer containing 320 mM sucrose and 10 mM Hepes-NaOH, pH 7.4 (containing 0.2 mM PMSF). Homogenate was centrifuged for 10 min at 1,000 g to remove crude nuclear fraction (P1). The supernatant (S1) was centrifuged at 9,000 g for 15 min to produce a pellet (P2) and supernatant (S2). The S2 was centrifuged at 100,000 g for 1 h to produce a pellet (P3; microsomal fraction) and supernatant (S3). The P2 fraction was resuspended in the homogenization buffer. Discontinuous sucrose gradients containing 3 ml of the resuspended P2 material and 3 ml each of 0.8, 1.0, and 1.2 M sucrose solutions in 10 mM Hepes-NaOH, pH 7.4, were run for 2 h at 58,000 g (SW41 rotor; Beckman Coulter). The band between 1.0 and 1.2 M sucrose was obtained as a synaptosome fraction. This synaptosome fraction was extracted with ice-cold 0.5% Triton X-100 in 0.16 M sucrose and 6 mM Tris-HCl, pH 8.1, and then centrifuged at 32,800 g for 20 min to divide into soluble and insoluble fractions (Ins1; PSD-1). The pellet was resuspended in 0.5% Triton X-100, 0.16 M sucrose, and 6 mM Tris-HCl, pH 8.1, and centrifuged at 200,000 g for 1 h to produce a pellet (Ins2; PSD-2). 50 µg of proteins of each fraction was analyzed by Western blotting.
Statistical analysis
The results are expressed as mean ± SD. Statistical comparisons between groups were performed by the Student's t test.
Online supplemental material Fig. S1 shows that synaptic PSD-95 accumulation upon activity blockade does not require protein synthesis. Fig. S2 shows the specific detection of PSD-95 palmitoylation by biochemical approaches. Fig. S3 shows that DHHC2 and -3 and PSD-95 dominantly express as compared with other family proteins in the hippocampus. Fig. S4 shows that DHHC2 translocates near the postsynaptic sites upon activity blockade. Fig. S5 shows that DHHC2 and PSD-95 are necessary for homeostatic increase of GluR2 as well as GluR1. Video 1 shows PSD-95-GFP dynamics in neurons by time-lapse TIRFM imaging and shows the increased accumulation of PSD-95-GFP upon Kyn treatment. Video 2 shows that CHX treatment does not inhibit Kyn-induced PSD-95-GFP increase at the synapse. Video 3 shows that activity-sensitive trafficking of PSD-95 is regulated by DHHC2. Video 4 shows activity-sensitive trafficking of DHHC2. Video 5 shows the specificity of pH-GluR1 imaging. Video 6 shows AMPAR (pH-GluR1) dynamics by time-lapse TIRFM imaging. Video 7 shows that pH-GluR1 intensity gradually and continually increases over 12 h upon TTX treatment. Video 8 shows the epitope of GluR1 (EMD) or GluR2 (Millipore) by incubating neurons in conditioned medium for 15 min at 37°C. Neurons were then fixed with 2% paraformaldehyde for 20 min and blocked as described above. Surface GluR1 and GluR2 were visualized with Alexa Fluor 488-conjugated secondary antibody. Fluorescent images were taken with a confocal laser-scanning microscopy system (LSM5 Exciter; Carl Zeiss, Inc.) equipped with a Plan-Apochromat 63× NA 1.40 oil immersion objective lens. For knockdown experiments, 8-12-DIV neurons were transfected with pCAGGS-mCherry-miR vectors by Lipofectamine 2000. At 8-10 d after transfection, neurons were stained with anti-DHHC2, DHHC3, PSD-95, GluR1, GluR2, and stargazin/TARP antibodies. To quantitate the intensity of PSD-95 clusters and surface GluR1, surface GluR2, or TARP clusters (costained with PSD-95), we randomly chose 10-15 fields from two independent neuronal cultures (on treated and age-matched sister control cultures) and analyzed the three largest caliber proximal dendrites (20 µm long; at least 400 clusters). We measured the mean intensities of individual clusters (>1 µm diameter) along these dendritic segments. Microscope control and all image analyses were performed with ZEN software (Carl Zeiss, Inc.). Brightness and contrast adjustments were applied to the whole image using Photoshop CS3 (Adobe Systems, Inc.). For some experiments, immunolabeled samples were observed by TIRFM and epifluorescent microscopy.
ABE method
The ABE method was performed as previously described (Roth et al., 2006; Kang et al., 2008) and modified for cultured neurons. After treating 18-28-DIV hippocampal neurons (5 × 10 5 cells/6-well dish) with the indicated antagonists or inhibitors, neurons were washed with PBS containing 10 mM N-ethyl-maleimide (NEM) twice and solubilized with 0.1 ml of lysis buffer (LB; 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 50 mM NaCl) containing 2% SDS and 10 mM NEM. After 15 min of extraction, LB with 2% Triton X-100 and 10 mM NEM was added to a final volume of 1 ml and incubated for 1 h at 4°C. After centrifugation at 20,000 g for 10 min, the supernatants were precipitated by the chloroform-methanol (CM) method (Wessel and Flugge, 1984) . Precipitated protein was solubilized in 0.2 ml SB (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 4% SDS) containing 10 mM NEM at 37°C for 10 min. The protein was diluted into 0.8 ml LB with 0.2% Triton X-100 and 1 mM NEM and incubated overnight at 4°C. NEM was removed by three sequential CM precipitations. Precipitated protein was solubilized in 0.2 ml of buffer SB, and then 0.8 ml HB (1 M hydroxylamine, pH 7.5, 150 mM NaCl, 0.2% Triton X-100, and 1 mM biotin-HPDP) or buffer TB (1 M Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Triton X-100, and 1 mM biotin-HPDP) was added. The mixture was incubated for 1 h at room temperature and subjected to CM precipitation. The precipitated protein was dissolved in 0.2 ml SB, diluted into 0.8 ml LB containing 150 mM NaCl, 0.2% Triton X-100, and 200 µM biotin-HPDP, and incubated for 1 h at room temperature. Free biotin-HPDP was removed by CM precipitation. The precipitated protein was solubilized in 100 µl of buffer UB (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 2% SDS) and diluted in 900 µl LB with 0.2% Triton X-100. After brief centrifugation, the supernatant was incubated with 30 µl neutravidin-agarose (Thermo Fisher Scientific) for 1 h at 4°C. After washing the beads with LB containing 0.1% SDS and 0.2% Triton X-100, bound proteins were suspended in SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, and 0.001% bromophenol blue) with 10 mM DTT (without ME; ME) and boiled at 90°C for 2 min. To see the palmitoylation-dependent mobility shift of PSD-95, the cell lysate was treated similarly (ME). To reduce the sample completely, the lysate was separately treated with SDS-PAGE sample buffer with 2% ME at 100°C for 5 min (+ME). Samples were subjected to SDS-PAGE and Western blotting with the indicated antibodies.
In vivo palmitate labeling Hippocampal neurons were infected with Semliki forest virus to express GFP or GFP-tagged DN DHHC2/15 . At 24 h after infection, cells were labeled for 2 h in neurobasal media containing 3 mCi/ml [ 3 H]palmitic acid (PerkinElmer) either in the presence or absence of 10 mM Kyn. Labeled cells were washed with PBS and resuspended in 0.15 ml LB A (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 100 mM NaCl, and 1% SDS). After 5 min of extraction, 1% Triton X-100 was added to a final volume of 1.5 ml. After centrifugation at 20,000 g for 10 min, the supernatants were incubated with rabbit anti-PSD-95 antibody for 1 h and then incubated for 1 h with 30 µl protein A-Sepharose (GE Healthcare) at 4°C. Immunoprecipitates were washed three times with buffer containing 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl, and 1% Triton X-100. Immunoprecipitated PSD-95 was suspended in SDS sample buffer. For fluorography, protein samples were separated by SDS-PAGE. Gels were
